Browse > Article
http://dx.doi.org/10.14348/molcells.2021.0037

Genome Edited Sirt1-Overexpressing Human Mesenchymal Stem Cells Exhibit Therapeutic Effects in Treating Collagen-Induced Arthritis  

Chae, Dong-Sik (Department of Orthopedic Surgery, International St. Mary's Hospital, Catholic Kwandong University College of Medicine)
Han, Seongho (Department of Family Medicine, Dong-A University Medical Center, Dong-A University College of Medicine)
Lee, Min-Kyung (Department of Dental Hygine, Dong-Eui Universtigy)
Kim, Sung-Whan (Department Medicine, Catholic Kwandong University College of Medicine)
Publication Information
Molecules and Cells / v.44, no.4, 2021 , pp. 245-253 More about this Journal
Abstract
Even though mesenchymal stem cells (MSCs) are known for cartilage regeneration, their therapeutic efficacy needs to be enhanced. In the present study, we produced genome-edited silent information regulator 2 type 1 (Sirt1)-overexpressing MSCs, and evaluated their therapeutic potential in a damaged cartilage mouse liver fibrosis model. The Sirt1 gene was successfully inserted into a 'safe harbor' genomic locus in amniotic mesenchymal stem cells (AMMs), and the chondrogenic properties of the Sirt1 gene overexpressing AMMs (AMM/S) were characterized using quantitative PCR and histology. Therapeutic potentials were investigated in a collagen-induced arthritis (CIA) mouse model. Chondrocyte-differentiated AMM/S expressed cartilage-specific genes and were positive for Safranin O staining. Transplantation of AMM/S attenuated CIA progression and suppressed T helper (Th)-17 cell activation while increasing the Treg cell population in CIA mice. Pro-inflammatory factors, such as interleukin (IL)-1β, IL-6, monocyte chemoattractant protein (MCP)-1, and tumor necrosis factor (TNF)-α were significantly decreased in AMM/S-injected joint tissues. In conclusion, genome-edited AMM/S may represent a safe and alternative therapeutic option for the treatment and repair of damaged cartilage, or in inflammatory joint arthritis.
Keywords
anti-inflammation; cell therapy; genome editing; mesenchymal stem cells; osteoarthritis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ou, X., Ying, J., Bai, X., Wang, C., and Ruan, D. (2020). Activation of SIRT1 promotes cartilage differentiation and reduces apoptosis of nucleus pulposus mesenchymal stem cells via the MCP1/CCR2 axis in subjects with intervertebral disc degeneration. Int. J. Mol. Med. 46, 1074-1084.   DOI
2 Aggarwal, S. and Pittenger, M.F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815-1822.   DOI
3 Alviano, F., Fossati, V., Marchionni, C., Arpinati, M., Bonsi, L., Franchina, M., Lanzoni, G., Cantoni, S., Cavallini, C., Bianchi, F., et al. (2007). Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro. BMC Dev. Biol. 7, 11.   DOI
4 Backesjo, C.M., Li, Y., Lindgren, U., and Haldosen, L.A. (2009). Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells. Cells Tissues Organs 189, 93-97.   DOI
5 Benabdallah, B.F., Allard, E., Yao, S., Friedman, G., Gregory, P.D., Eliopoulos, N., Fradette, J., Spees, J.L., Haddad, E., Holmes, M.C., et al. (2010). Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform. Cytotherapy 12, 394-399.   DOI
6 Choi, B., Chun, E., Kim, S.Y., Kim, M., Lee, K.Y., and Kim, S.J. (2012). Notch-induced hIL-6 production facilitates the maintenance of self-renewal of hCD34+ cord blood cells through the activation of Jak-PI3K-STAT3 pathway. Am. J. Pathol. 180, 351-364.   DOI
7 Choi, J.S., Jeong, I.S., Han, J.H., Cheon, S.H., and Kim, S.W. (2019). IL-10-secreting human MSCs generated by TALEN gene editing ameliorate liver fibrosis through enhanced anti-fibrotic activity. Biomater. Sci. 7, 1078-1087.   DOI
8 Delgado, M., Abad, C., Martinez, C., Leceta, J., and Gomariz, R.P. (2001). Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7, 563-568.   DOI
9 Don, R., Cox, P., Wainwright, B., Baker, K., and Mattick, J. (1991). 'Touchdown' PCR to circumvent spurious priming during gene amplification. Nucleic Acids Res. 19, 4008.   DOI
10 Dvir-Ginzberg, M. and Steinmeyer, J. (2013). Towards elucidating the role of SirT1 in osteoarthritis. Front. Biosci. (Landmark Ed.) 18, 343-355.   DOI
11 Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., and Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821.   DOI
12 Peng, L., Yuan, Z., Ling, H., Fukasawa, K., Robertson, K., Olashaw, N., Koomen, J., Chen, J., Lane, W.S., and Seto, E. (2011). SIRT1 deacetylates the DNA methyltransferase 1 (DNMT1) protein and alters its activities. Mol. Cell. Biol. 31, 4720-4734.   DOI
13 Qasim, M., Le, N.X.T., Nguyen, T.P.T., Chae, D.S., Park, S.J., and Lee, N.Y. (2020). Nanohybrid biodegradable scaffolds for TGF-beta3 release for the chondrogenic differentiation of human mesenchymal stem cells. Int. J. Pharm. 581, 119248.   DOI
14 Razawy, W., Asmawidjaja, P.S., Mus, A.M., Salioska, N., Davelaar, N., Kops, N., Oukka, M., Alves, C.H., and Lubberts, E. (2020). CD4(+) CCR6(+) T cells, but not gammadelta T cells, are important for the IL-23R-dependent progression of antigen-induced inflammatory arthritis in mice. Eur. J. Immunol. 50, 245-255.   DOI
15 Buhrmann, C., Busch, F., Shayan, P., and Shakibaei, M. (2014). Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells. J. Biol. Chem. 289, 22048-22062.   DOI
16 Chang, H.K., Kim, P.H., Cho, H.M., Yum, S.Y., Choi, Y.J., Son, Y., Lee, D., Kang, I., Kang, K.S., Jang, G., et al. (2016). Inducible HGF-secreting human umbilical cord blood-derived MSCs produced via TALEN-mediated genome editing promoted angiogenesis. Mol. Ther. 24, 1644-1654.   DOI
17 Farhang, N., Brunger, J.M., Stover, J.D., Thakore, P.I., Lawrence, B., Guilak, F., Gersbach, C.A., Setton, L.A., and Bowles, R.D. (2017). (*) CRISPR-based epigenome editing of cytokine receptors for the promotion of cell survival and tissue deposition in inflammatory environments. Tissue Eng. Part A 23, 738-749.   DOI
18 Gabay, O., Zaal, K.J., Sanchez, C., Dvir-Ginzberg, M., Gagarina, V., Song, Y., He, X.H., and McBurney, M.W. (2013). Sirt1-deficient mice exhibit an altered cartilage phenotype. Joint Bone Spine 80, 613-620.   DOI
19 Hedbom, E. and Hauselmann, H.J. (2002). Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell. Mol. Life Sci. 59, 45-53.   DOI
20 Jang, K.H., Hwang, Y., and Kim, E. (2020). PARP1 impedes SIRT1-mediated autophagy during degeneration of the retinal pigment epithelium under oxidative stress. Mol. Cells 43, 632-644.   DOI
21 Kehoe, O., Cartwright, A., Askari, A., El Haj, A.J., and Middleton, J. (2014). Intra-articular injection of mesenchymal stem cells leads to reduced inflammation and cartilage damage in murine antigen-induced arthritis. J. Transl. Med. 12, 157.   DOI
22 Kim, S.W., Kim, H., Cho, H.J., Lee, J.U., Levit, R., and Yoon, Y.S. (2010). Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. J. Am. Coll. Cardiol. 56, 593-607.   DOI
23 Korbie, D.J. and Mattick, J.S. (2008). Touchdown PCR for increased specificity and sensitivity in PCR amplification. Nat. Protoc. 3, 1452-1456.   DOI
24 Matsushita, T., Sasaki, H., Takayama, K., Ishida, K., Matsumoto, T., Kubo, S., Matsuzaki, T., Nishida, K., Kurosaka, M., and Kuroda, R. (2013). The overexpression of SIRT1 inhibited osteoarthritic gene expression changes induced by interleukin-1beta in human chondrocytes. J. Orthop. Res. 31, 531-537.   DOI
25 Tsuji, H., Miyoshi, S., Ikegami, Y., Hida, N., Asada, H., Togashi, I., Suzuki, J., Satake, M., Nakamizo, H., Tanaka, M., et al. (2010). Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ. Res. 106, 1613-1623.   DOI
26 Wu, C.C., Liu, F.L., Sytwu, H.K., Tsai, C.Y., and Chang, D.M. (2016). CD146+ mesenchymal stem cells display greater therapeutic potential than CD146- cells for treating collagen-induced arthritis in mice. Stem Cell Res. Ther. 7, 23.   DOI
27 Han, J.H., Han, S., Jeong, I.S., Cheon, S.H., and Kim, S.W. (2020). Minicircle-based GCP-2 ex vivo gene therapy enhanced the reepithelialization and angiogenic capacity. J. Tissue Eng. Regen. Med. 14, 829-839.   DOI